Clinical Trials for Mesothelioma Patients: NGR-hTNF as Single Agent Contact Information
Read more here to obtain contact information for the current clinical trial being conducted to study NGR-htNF Vorinostat in patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.
Locations:
Istituto Europeo Oncologico
Milan, Italy
Istituto Clinico Humanitas
Rozzano, Italy
Contact: Federico Caligaris-Cappio, MD
+39 02 2643 ext 2529
If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.


Mesothelioma patient exclusion criteria for clinical trial of hTNF